Published in J Diabetes Res on March 19, 2017
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
An integrated encyclopedia of DNA elements in the human genome. Nature (2012) 64.73
Chromatin modifications and their function. Cell (2007) 55.98
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature (2002) 28.79
Landscape of transcription in human cells. Nature (2012) 20.18
Evolution and functions of long noncoding RNAs. Cell (2009) 17.54
Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet (2012) 15.21
Large-scale transcriptional activity in chromosomes 21 and 22. Science (2002) 14.01
miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res (2013) 13.41
Genome regulation by long noncoding RNAs. Annu Rev Biochem (2012) 11.70
Molecular mechanisms of long noncoding RNAs. Mol Cell (2011) 11.44
Chronic kidney disease: global dimension and perspectives. Lancet (2013) 8.16
MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene (2003) 7.90
Epigenetic modifications and human disease. Nat Biotechnol (2010) 7.29
lincRNAs: genomics, evolution, and mechanisms. Cell (2013) 6.50
Gene index analysis of the human genome estimates approximately 120,000 genes. Nat Genet (2000) 6.09
MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci U S A (2007) 4.92
Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med (2008) 4.25
TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol (2009) 4.05
Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med (1989) 3.67
Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med (2010) 3.60
Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Res (2004) 3.11
Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab (2009) 2.76
Emerging roles for natural microRNA sponges. Curr Biol (2010) 2.62
miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. J Am Soc Nephrol (2010) 2.51
MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis. Genome Res (2008) 2.51
Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. J Am Soc Nephrol (2010) 2.45
Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus. BMC Med Genomics (2010) 2.34
A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cells. Kidney Int (2011) 2.30
Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes. Nat Med (2013) 2.29
E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta. Diabetes (2010) 1.85
Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy. J Am Soc Nephrol (2012) 1.70
Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development. Genome Biol (2013) 1.52
Epigenetic phenomena linked to diabetic complications. Nat Rev Endocrinol (2010) 1.51
Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause? Kidney Int (2005) 1.45
Epigenetic histone methylation modulates fibrotic gene expression. J Am Soc Nephrol (2010) 1.44
MicroRNA isolation and stability in stored RNA samples. Biochem Biophys Res Commun (2009) 1.43
An endoplasmic reticulum stress-regulated lncRNA hosting a microRNA megacluster induces early features of diabetic nephropathy. Nat Commun (2016) 1.40
miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia (2013) 1.39
DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy. Epigenetics (2011) 1.33
Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells. Genome Res (2011) 1.22
Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms. Nat Rev Nephrol (2010) 1.16
Transforming growth factor-β-induced cross talk between p53 and a microRNA in the pathogenesis of diabetic nephropathy. Diabetes (2013) 1.15
Diabetic nephropathy--emerging epigenetic mechanisms. Nat Rev Nephrol (2014) 1.15
Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus. Cell Death Dis (2014) 1.11
Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc. Proc Natl Acad Sci U S A (2012) 1.11
Dietary factors, epigenetic modifications and obesity outcomes: progresses and perspectives. Mol Aspects Med (2012) 1.10
TGF-β induces acetylation of chromatin and of Ets-1 to alleviate repression of miR-192 in diabetic nephropathy. Sci Signal (2013) 0.97
Identification of novel long noncoding RNAs associated with TGF-β/Smad3-mediated renal inflammation and fibrosis by RNA sequencing. Am J Pathol (2013) 0.95
Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells. J Cell Mol Med (2015) 0.94
MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets. Ann N Y Acad Sci (2015) 0.92
The role of microRNAs in diabetic nephropathy. J Diabetes Res (2014) 0.91
MicroRNA-21 in glomerular injury. J Am Soc Nephrol (2014) 0.89
Exercise and inflammation-related epigenetic modifications: focus on DNA methylation. Exerc Immunol Rev (2015) 0.85
Genome-wide studies to identify risk factors for kidney disease with a focus on patients with diabetes. Nephrol Dial Transplant (2015) 0.83
Urinary MicroRNA Profiling Predicts the Development of Microalbuminuria in Patients with Type 1 Diabetes. J Clin Med (2015) 0.82
Diabetes Induces Aberrant DNA Methylation in the Proximal Tubules of the Kidney. J Am Soc Nephrol (2015) 0.81
Diabetic kidney disease. Nat Rev Dis Prim (2015) 0.81
miRNAs in Urine Extracellular Vesicles as Predictors of Early-Stage Diabetic Nephropathy. J Diabetes Res (2016) 0.81
Long noncoding RNA Tug1 regulates mitochondrial bioenergetics in diabetic nephropathy. J Clin Invest (2016) 0.80
MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy. Curr Diab Rep (2016) 0.79
Epigenetic Mechanisms in Diabetic Kidney Disease. Curr Diab Rep (2016) 0.78
Urinary Exosomal microRNA-451-5p Is a Potential Early Biomarker of Diabetic Nephropathy in Rats. PLoS One (2016) 0.76
Improvements in the Management of Diabetic Nephropathy. Rev Diabet Stud (2015) 0.76
Genetics and Epigenetics of Diabetic Nephropathy. Kidney Dis (Basel) (2015) 0.76
Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling. PLoS One (2013) 1.26
Suramin alleviates glomerular injury and inflammation in the remnant kidney. PLoS One (2012) 0.85
Delayed administration of suramin attenuates the progression of renal fibrosis in obstructive nephropathy. J Pharmacol Exp Ther (2011) 0.84
Enhancer of Zeste Homolog 2 Inhibition Attenuates Renal Fibrosis by Maintaining Smad7 and Phosphatase and Tensin Homolog Expression. J Am Soc Nephrol (2015) 0.84
Autophagy in Chronic Kidney Diseases. Kidney Dis (Basel) (2016) 0.79
Mechanistic Insight and Management of Diabetic Nephropathy: Recent Progress and Future Perspective. J Diabetes Res (2017) 0.78
Pharmacological targeting of BET proteins inhibits renal fibroblast activation and alleviates renal fibrosis. Oncotarget (2016) 0.75
Podocyte Autophagy: A Potential Therapeutic Target to Prevent the Progression of Diabetic Nephropathy. J Diabetes Res (2017) 0.75
Antithrombin III prevents progression of chronic kidney disease following experimental ischaemic-reperfusion injury. J Cell Mol Med (2017) 0.75
Histone deacetylase 6 inhibition counteracts the epithelial-mesenchymal transition of peritoneal mesothelial cells and prevents peritoneal fibrosis. Oncotarget (2017) 0.75
Diabetic Nephropathy: From Pathophysiology to Treatment. J Diabetes Res (2017) 0.75
Nintedanib,a triple tyrosine kinase inhibitor,attenuates renal fibrosis in chronic kidney disease. Clin Sci (Lond) (2017) 0.75